Informatie:
Fout:
ID
34317
Beschrijving
Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT01352416
Link
https://clinicaltrials.gov/show/NCT01352416
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Heart; Dysfunction Postoperative, Cardiac Surgery NCT01352416
Eligibility Heart; Dysfunction Postoperative, Cardiac Surgery NCT01352416
- StudyEvent: Eligibility
Similar models
Eligibility Heart; Dysfunction Postoperative, Cardiac Surgery NCT01352416
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
indications for cardiac surgery (cabg, valve surgery or cabg and valve surgery, able to provide informed consent.
boolean
ID.2
Item
documented atrial fibrillation within the previous 3 months
boolean
ID.3
Item
ongoing therapy with suppressive antiarrhythmic drugs
boolean
ID.4
Item
patient currently on digoxin
boolean
ID.5
Item
emergent surgery
boolean
ID.6
Item
patient receiving hemodialysis
boolean
ID.7
Item
concomitant use of ketoconazole, diltiazem, verapamil
boolean
ID.8
Item
known tolerance or hypersensitivity to ranolazine
boolean
ID.9
Item
pregnant individuals
boolean
ID.10
Item
maze procedure performed during concurrent cardiac surgery
boolean